Status:
COMPLETED
Outcomes in Ovarian Cancer and Fallopian Tube Cancer Patients Using Complementary Alternative Medicine
Lead Sponsor:
Masonic Cancer Center, University of Minnesota
Collaborating Sponsors:
Randy Shaver Cancer Research Fund
Conditions:
Ovarian Cancer
Peritoneal Primary Cancer
Eligibility:
FEMALE
Phase:
NA
Brief Summary
RATIONALE: Chemotherapy, such as paclitaxel and carboplatin, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Hypnosis, massage ...
Detailed Description
OBJECTIVES: Primary * Determine whether quality of life is improved in patients with epithelial ovarian, fallopian tube or primary peritoneal cavity cancer receiving hypnosis, massage therapy, and h...
Eligibility Criteria
Inclusion
- Newly diagnosed epithelial ovarian, primary peritoneal or fallopian tube cancer, any pathologic type or stage, who will receive 6 cycles of chemotherapy.
- Patients must have signed an informed consent
Exclusion
- Previous cancer other than skin cancer
- Previous chemotherapy experience
- Active substance abuse
- Schizophrenia
- Pregnant or lactating
Key Trial Info
Start Date :
May 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2010
Estimated Enrollment :
43 Patients enrolled
Trial Details
Trial ID
NCT00293293
Start Date
May 1 2005
End Date
January 1 2010
Last Update
December 28 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Masonic Cancer Center at University of Minnesota
Minneapolis, Minnesota, United States, 55455